Macdonald Alistair 4
4 · Syneos Health, Inc. · Filed Apr 5, 2021
Insider Transaction Report
Form 4
Macdonald Alistair
Chief Operating Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2021-04-01$40.12/sh+17,398$698,008→ 231,907 total - Sale
Class A Common Stock
2021-04-01$77.61/sh−13,720$1,064,823→ 217,514 total - Sale
Class A Common Stock
2021-04-01$76.11/sh−673$51,223→ 231,234 total - Sale
Class A Common Stock
2021-04-01$77.92/sh−3,005$234,144→ 214,509 total - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2021-04-01−17,398→ 0 totalExercise: $40.12Exp: 2025-06-30→ Class A Common Stock (17,398 underlying)
Footnotes (5)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2020.
- [F2]The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $75.84 to $76.81, inclusive. The reporting person undertakes to provide Syneos Health, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $76.87 to $77.86, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $77.87 to $78.10, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The shares subject to this option vested in four approximately equal annual installments on June 30, 2016; June 30, 2017; June 30, 2018; and June 30, 2019.